{
    "organizations": [],
    "uuid": "fbe263d4b6aaf65444c5c7635430180a55232a38",
    "author": "",
    "url": "https://www.reuters.com/article/brief-syros-announces-new-preclinical-da/brief-syros-announces-new-preclinical-data-on-sy-1365-showing-potent-anti-tumor-activity-in-multiple-models-of-heavily-pretreated-ovarian-cancer-idUSFWN1RT0B1",
    "ord_in_thread": 0,
    "title": "BRIEF-Syros Announces New Preclinical Data On SY-1365 Showing Potent Anti-Tumor Activity In Multiple Models Of Heavily Pretreated Ovarian Cancer",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Market News April 16, 2018 / 12:03 PM / Updated 11 minutes ago BRIEF-Syros Announces New Preclinical Data On SY-1365 Showing Potent Anti-Tumor Activity In Multiple Models Of Heavily Pretreated Ovarian Cancer Reuters Staff 1 Min Read \nApril 16 (Reuters) - Syros Pharmaceuticals Inc: \n* SYROS ANNOUNCES NEW PRECLINICAL DATA ON SY-1365 SHOWING POTENT ANTI-TUMOR ACTIVITY IN MULTIPLE MODELS OF HEAVILY PRETREATED OVARIAN CANCER \n* SYROS PHARMACEUTICALS INC - ON TRACK TO REPORT DATA FROM DOSE ESCALATION PORTION OF PHASE 1 TRIAL IN Q4 OF 2018 \n* SYROS PHARMACEUTICALS INC - EXPECT TO OPEN EXPANSION COHORTS IN PHASE 1 TRIAL IN MID-2018 Source text for Eikon: Further company coverage:",
    "published": "2018-04-16T15:02:00.000+03:00",
    "crawled": "2018-04-16T15:23:12.011+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "market",
        "news",
        "april",
        "pm",
        "updated",
        "minute",
        "ago",
        "announces",
        "new",
        "preclinical",
        "data",
        "showing",
        "potent",
        "activity",
        "multiple",
        "model",
        "heavily",
        "pretreated",
        "ovarian",
        "cancer",
        "reuters",
        "staff",
        "min",
        "read",
        "april",
        "reuters",
        "syros",
        "pharmaceutical",
        "inc",
        "syros",
        "announces",
        "new",
        "preclinical",
        "data",
        "showing",
        "potent",
        "activity",
        "multiple",
        "model",
        "heavily",
        "pretreated",
        "ovarian",
        "cancer",
        "syros",
        "pharmaceutical",
        "inc",
        "track",
        "report",
        "data",
        "dose",
        "escalation",
        "portion",
        "phase",
        "trial",
        "q4",
        "syros",
        "pharmaceutical",
        "inc",
        "expect",
        "open",
        "expansion",
        "cohort",
        "phase",
        "trial",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}